Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year

NCT04588246 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT04588246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04588246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Terminated
Start date
August 5, 2021
Completion date
August 6, 2024
Enrollment
19 (actual)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, metastatic lung non-small cell carcinoma, metastatic lung small cell carcinoma, metastatic malignant breast neoplasm, metastatic malignant digestive system neoplasm, metastatic malignant neoplasm in the brain, metastatic malignant solid neoplasm, metastatic melanoma, metastatic renal cell carcinoma, recurrent brain neoplasm, stage iv lung cancer ajcc v8, stage iv renal cell cancer ajcc v8